Ajanta Pharma Q1 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
2,775.90
-13.15 (-0.47%)
-13.15 (-0.47%)Volume3.92 K
Updated: Fri 18 Jul, 2025 | 15:29:52
NSE
2,772.80-13.60 (-0.49%)
-13.60 (-0.49%)Volume70.71 K
Updated: Fri 18 Jul, 2025 | 15:52:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 848.54 | 913.04 | 4.76% |
| Depreciation/ Amortization | 33.97 | 39.78 | -0.82% |
| Operating Income | 296.38 | 257.37 | 21.43% |
| Net Income | 245.77 | 225.26 | 21.24% |
| Other Operating Expenses Total | 262.94 | 310.06 | -5.37% |
| Net Income Before Taxes | 322.12 | 269.41 | 15.85% |
| Total Revenue | 1,144.92 | 1,170.41 | 8.62% |
| Selling/ General/ Admin Expenses Total | 283.78 | 279.78 | 21.53% |
| Diluted Normalized EPS | 19.53 | 18.04 | 21.38% |